Spit test could shrink years-long wait for diagnosis that affects 190M women

Key Points:

• A new saliva-based test called Endotest has been approved by the UK's National Institute for Health and Care Excellence (NICE) to help detect endometriosis more quickly and less invasively, potentially shortening the average 11-year wait for diagnosis.
• Endometriosis affects about 1 in 10 women worldwide and involves uterine tissue growing outside the uterus, causing symptoms like chronic pain, fatigue, infertility, and other systemic issues, though diagnosis is often challenging due to symptom overlap and lack of effective diagnostic tools.
• Traditional diagnostic methods can be invasive and inconclusive, leading to endometriosis being one of the most commonly missed diagnoses; the new test identifies microRNAs in saliva that indicate the presence of the disease, facilitating earlier detection.
• Early diagnosis through Endotest can improve treatment outcomes, prevent severe complications such as "frozen pelvis," and reduce the burden on healthcare resources by minimizing the need for invasive surgeries.
• Experts emphasize that while the test is not a standalone diagnostic tool, it represents a significant advancement in recognizing and managing endometriosis, offering hope for better patient care and faster access to treatment.